AwesomeCapital: Avadel gains during hearing over dispute on FDA approval of a sleep disorder drug

Friday, May 10, 2024

Avadel gains during hearing over dispute on FDA approval of a sleep disorder drug

Avadel Pharmaceutical (NASDAQ:AVDL) rose 3% amid a hearing over the Federal Drug Administration's approval for a sleep disorder drug

https://seekingalpha.com/news/4104805-avadel-pharma-gains-during-hearing-over-dispute-on-fda-approval-of-a-sleep-disorder-drug

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)